Methadone Clinical Use: Sucampo Pharmaceuticals, Inc. Reports First Quarter 2012 Financial and

Methadone Clinical Use in the News

Methadone Clinical Use: Sucampo Pharmaceuticals, Inc. Reports First Quarter 2012 Financial and
As previously reported, the third phase 3 clinical trial of lubiprostone for the treatment of OBD in patients with chronic non-cancer pain, excluding those taking methadone, met the primary endpoint of the overall spontaneous bowel movement (SBM) …
Read more on MarketWatch (press release)



Methadone Clinical Use: Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide
This Phase 3 clinical trial was a randomized-withdrawal, placebo-controlled study. It enrolled adult patients who had moderate to severe, chronic painful DPN for six months or more and a history of analgesic use for painful DPN for three months or more …
Read more on MarketWatch (press release)

More Methadone Clinical Use Information…